{"id":{"repo_id":"edinburgh","oai_identifier":"oai:era.ed.ac.uk:1842/38167"},"canonical_url":"https://search.ndltd.org/etd/edinburgh/oai:era.ed.ac.uk:1842/38167","repository":{"repo_id":"edinburgh","name":"University of Edinburgh","base_url":"https://era.ed.ac.uk/server/oai/request"},"display":{"title":"Relationship between inflammation, DNA methylation and cognitive ability","abstract":"Maintenance of cognitive function in older age is becoming increasingly relevant due to the ageing population and the personal and socioeconomic consequences associated with cognitive decline and dementia. Identification of the determinants of cognitive impairment in older age is thus critical. The role of inflammation has become a key focus in the field of cognitive ageing. Whereas inflammatory dysregulation may be evident in age-related cognitive decline, the extent, directionality, and progression of the association is still not clear. Additional approaches are needed to delineate the relationship. Alongside inflammation, there is increasing interest in the role of the epigenetic mechanism of DNA methylation in cognitive ageing. The aim of this thesis is to investigate the associations between inflammatory markers (C-reactive protein [CRP] and interleukin-6 [IL-6]), DNA methylation, and cognitive ability. A variety of approaches are utilised to examine these interrelationships in two large cohort datasets ± the Lothian Birth Cohort 1936 (LBC1936; n=1,091) and Generation Scotland (GS; n=7,028). Following introductory chapters presenting overviews of cognitive ability, inflammation and DNA methylation, and summarising the two population cohorts, the empirical work of the thesis is presented in Chapters 5 to 9. Chapters 5 and 6 focus on investigating the association between DNA methylation-based biomarkers of ageing ('epigenetic clocks') ZiWh boWh inflammaWion and cognitive ability, respectively. In Chapter 5, the dynamics of CRP and IL-6 are investigated over the eighth decade, and two epigenetic clocks ± labelled Hannum and Horvath - are used to investigate the relationship between the two inflammatory markers and accelerated epigenetic ageing. The results indicate divergent longitudinal trajectories of the inflammatory markers, but a consistent positive association between both CRP and IL-6 with the Hannum measure of age acceleration (EEAA). In Chapter 6, a phenome-wide association study of a novel epigenetic clock incorporating inflammatory and immune markers ± DNA methylation PhenoAge ± is conducted, primarily in relation to cognitive outcomes, but also to a range of other health phenotypes. Here, the epigenetic biomarker displayed cross-sectional associations with various cognitive outcomes at the age of ~70 years in LBC1936. However, adjusting for early life cognitive ability attenuated the associations, indicative of a reverse causation whereby those with higher childhood intelligence were more likely to have higher intelligence and lower epigenetic age acceleration in later life. Chapters 7 and 8 focus on DNA methylation predictors of CRP and IL-6 and establishing their associations with cognitive ability. The results from Chapter 7 suggest that a DNA methylation proxy for CRP may provide a more stable index of chronic inflammation compared to serum levels of the inflammatory protein. Additionally, the effect sizes of the association between the methylation proxy and cognitive ability were slightly larger than that of the serum measure, indicating it may better capture the relationship between inflammation and cognitive performance. Chapter 8 revealed similar results, with a DNA methylation proxy for IL-6 showing associations with previously established correlates of IL-6, and with general cognitive ability in the Generation Scotland cohort. These results highlight the utility of DNA methylation proxies of inflammatory mediators to gain additional insight into the relationship between inflammation and cognitive function. The final empirical chapter - Chapter 9 - coalesces the work of the thesis by assessing the aforementioned epigenetic clock and inflammation-related DNA methylation signatures that were previously investigated in blood, in post-mortem brain tissue in 14 of the LBC1936 participants. This chapter additionally examines how the DNA methylation patterns relate to burdens of the primary tissue-resident immune cell of the central nervous system - microglia. The results of this chapter provide preliminary evidence that the hippocampus may be particularly susceptible to epigenetic ageing and indicate a tentative link between a higher DNA methylation PhenoAge in the brain and increased microglial burdens. However, given the small sample size of this work, these initial patterns need further confirmation. Overall, the work presented in this thesis establishes evidence for a relationship between inflammation, DNA methylation and cognitive ability. Increased inflammation and lower cognitive ability was found to associate with accelerated biological ageing. Furthermore, novel inflammation-associated methylation patterns were developed and related to cognitive performance in order to improve our understanding of the interplay between inflammation and age-related health outcomes.","abstract_html":"Maintenance of cognitive function in older age is becoming increasingly relevant due to the ageing population and the personal and socioeconomic consequences associated with cognitive decline and dementia. Identification of the determinants of cognitive impairment in older age is thus critical. The role of inflammation has become a key focus in the field of cognitive ageing. Whereas inflammatory dysregulation may be evident in age-related cognitive decline, the extent, directionality, and progression of the association is still not clear. Additional approaches are needed to delineate the relationship. Alongside inflammation, there is increasing interest in the role of the epigenetic mechanism of DNA methylation in cognitive ageing. The aim of this thesis is to investigate the associations between inflammatory markers (C-reactive protein [CRP] and interleukin-6 [IL-6]), DNA methylation, and cognitive ability. A variety of approaches are utilised to examine these interrelationships in two large cohort datasets ± the Lothian Birth Cohort 1936 (LBC1936; n=1,091) and Generation Scotland (GS; n=7,028). Following introductory chapters presenting overviews of cognitive ability, inflammation and DNA methylation, and summarising the two population cohorts, the empirical work of the thesis is presented in Chapters 5 to 9. Chapters 5 and 6 focus on investigating the association between DNA methylation-based biomarkers of ageing (&#x27;epigenetic clocks&#x27;) ZiWh boWh inflammaWion and cognitive ability, respectively. In Chapter 5, the dynamics of CRP and IL-6 are investigated over the eighth decade, and two epigenetic clocks ± labelled Hannum and Horvath - are used to investigate the relationship between the two inflammatory markers and accelerated epigenetic ageing. The results indicate divergent longitudinal trajectories of the inflammatory markers, but a consistent positive association between both CRP and IL-6 with the Hannum measure of age acceleration (EEAA). In Chapter 6, a phenome-wide association study of a novel epigenetic clock incorporating inflammatory and immune markers ± DNA methylation PhenoAge ± is conducted, primarily in relation to cognitive outcomes, but also to a range of other health phenotypes. Here, the epigenetic biomarker displayed cross-sectional associations with various cognitive outcomes at the age of ~70 years in LBC1936. However, adjusting for early life cognitive ability attenuated the associations, indicative of a reverse causation whereby those with higher childhood intelligence were more likely to have higher intelligence and lower epigenetic age acceleration in later life. Chapters 7 and 8 focus on DNA methylation predictors of CRP and IL-6 and establishing their associations with cognitive ability. The results from Chapter 7 suggest that a DNA methylation proxy for CRP may provide a more stable index of chronic inflammation compared to serum levels of the inflammatory protein. Additionally, the effect sizes of the association between the methylation proxy and cognitive ability were slightly larger than that of the serum measure, indicating it may better capture the relationship between inflammation and cognitive performance. Chapter 8 revealed similar results, with a DNA methylation proxy for IL-6 showing associations with previously established correlates of IL-6, and with general cognitive ability in the Generation Scotland cohort. These results highlight the utility of DNA methylation proxies of inflammatory mediators to gain additional insight into the relationship between inflammation and cognitive function. The final empirical chapter - Chapter 9 - coalesces the work of the thesis by assessing the aforementioned epigenetic clock and inflammation-related DNA methylation signatures that were previously investigated in blood, in post-mortem brain tissue in 14 of the LBC1936 participants. This chapter additionally examines how the DNA methylation patterns relate to burdens of the primary tissue-resident immune cell of the central nervous system - microglia. The results of this chapter provide preliminary evidence that the hippocampus may be particularly susceptible to epigenetic ageing and indicate a tentative link between a higher DNA methylation PhenoAge in the brain and increased microglial burdens. However, given the small sample size of this work, these initial patterns need further confirmation. Overall, the work presented in this thesis establishes evidence for a relationship between inflammation, DNA methylation and cognitive ability. Increased inflammation and lower cognitive ability was found to associate with accelerated biological ageing. Furthermore, novel inflammation-associated methylation patterns were developed and related to cognitive performance in order to improve our understanding of the interplay between inflammation and age-related health outcomes.","abstract_has_math":false,"creators":["Stevenson, Anna Jane"],"institution":"The University of Edinburgh","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Marioni, Riccardo","Spires-Jones, Tara","Mcintosh, Andrew","McColl, Barry"],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-07-31","date_published":"2021-07-31","updated_at":"2026-11-19T03:35:01Z","subjects":["Alzheimer's Disease","epigenetic changes","DNA methylation","epigenetic clocks","predicted age","inflammation and cognitive ability","DNA methylation PhenoAge","microglia"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://dx.doi.org/10.7488/era/1434"],"render_values":[{"text":"http://dx.doi.org/10.7488/era/1434","href":"http://dx.doi.org/10.7488/era/1434","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1842/38167","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/1842/38167","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://era.ed.ac.uk/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aera.ed.ac.uk%3A1842%2F38167","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Marioni, Riccardo","Spires-Jones, Tara","Mcintosh, Andrew","McColl, Barry"]},{"key":"dc:contributor.sponsor","label":"Sponsor","values":["Wellcome Trust"]},{"key":"dc:creator","label":"Author","values":["Stevenson, Anna Jane"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2021-10-18T10:47:50Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2021-10-18T10:47:50Z"]},{"key":"dc:date.issued","label":"Date","values":["2021-07-31"]},{"key":"dc:publisher","label":"Institution","values":["The University of Edinburgh"]},{"key":"dc:relation.hasversion","label":"Dc Relation Hasversion","values":["McCartney DL, Stevenson AJ, Hillary RF, Walker RM, Bermingham ML, Morris SW, et al. Epigenetic signatures of starting and stopping smoking. EBioMedicine. 2018;37:214-20","Stevenson AJ, McCartney DL, Harris SE, Taylor AM, Redmond P, Starr JM, et al. Trajectories of inflammatory biomarkers over the eighth decade and their associations with immune cell profiles and epigenetic ageing. Clinical epigenetics. 2018;10(1):159-.","Stevenson AJ, McCartney DL, Hillary RF, Redmond P, Taylor AM, Zhang Q, et al. Childhood intelligence attenuates the association between biological ageing and health outcomes in later life. Translational Psychiatry. 2019;9(1):323","Stevenson AJ, McCartney DL, Hillary RF, Campbell A, Morris SW, Bermingham ML, et al. Characterisation of an inflammation-related epigenetic score and its association with cognitive ability. Clinical epigenetics. 2020;12(1):113","McCartney DL, Hillary RF, Stevenson AJ, Ritchie SJ, Walker RM, Zhang Q, et al. Epigenetic prediction of complex traits and death. Genome Biology. 2018;19(1):136","McCartney DL, Stevenson AJ, Walker RM, Gibson J, Morris SW, Campbell A, et al. Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease. Alzheimers Dement (Amst). 2018;10:429- 37.","Stevenson AJ, McCartney DL, Hillary RF, Campbell A, Morris SW, Bermingham ML, et al. Characterisation of an inflammation-related epigenetic score and its association with cognitive ability. bioRxiv. 2019:802009","Hillary RF, Stevenson AJ, Cox SR, McCartney DL, Harris SE, Seeboth A, et al. An epigenetic predictor of death captures multi-modal measures of brain health. Molecular Psychiatry. 2019.","Stevenson AJ, Gadd DA, Hillary RF, McCartney DL, Campbell A, Walker RM, et al. Creating and validating a DNA methylation-based proxy for Interleukin-6. medRxiv. 2020:2020.07.20.20156935.","Conole ELS, Stevenson AJ, Green C, Harris SE, Maniega SM, Harris MA, et al. An epigenetic proxy of chronic inflammation outperforms serum levels as a biomarker of brain ageing. medRxiv. 2020:2020.10.08.20205245"]},{"key":"dc:type","label":"Dc Type","values":["Thesis or Dissertation"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["Doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["PhD Doctor of Philosophy"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Alzheimer's Disease","epigenetic changes","DNA methylation","epigenetic clocks","predicted age","inflammation and cognitive ability","DNA methylation PhenoAge","microglia"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1842/38167","http://dx.doi.org/10.7488/era/1434"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Maintenance of cognitive function in older age is becoming increasingly relevant due to the ageing population and the personal and socioeconomic consequences associated with cognitive decline and dementia. Identification of the determinants of cognitive impairment in older age is thus critical. The role of inflammation has become a key focus in the field of cognitive ageing. Whereas inflammatory dysregulation may be evident in age-related cognitive decline, the extent, directionality, and progression of the association is still not clear. Additional approaches are needed to delineate the relationship. Alongside inflammation, there is increasing interest in the role of the epigenetic mechanism of DNA methylation in cognitive ageing. The aim of this thesis is to investigate the associations between inflammatory markers (C-reactive protein [CRP] and interleukin-6 [IL-6]), DNA methylation, and cognitive ability. A variety of approaches are utilised to examine these interrelationships in two large cohort datasets ± the Lothian Birth Cohort 1936 (LBC1936; n=1,091) and Generation Scotland (GS; n=7,028). Following introductory chapters presenting overviews of cognitive ability, inflammation and DNA methylation, and summarising the two population cohorts, the empirical work of the thesis is presented in Chapters 5 to 9. Chapters 5 and 6 focus on investigating the association between DNA methylation-based biomarkers of ageing ('epigenetic clocks') ZiWh boWh inflammaWion and cognitive ability, respectively. In Chapter 5, the dynamics of CRP and IL-6 are investigated over the eighth decade, and two epigenetic clocks ± labelled Hannum and Horvath - are used to investigate the relationship between the two inflammatory markers and accelerated epigenetic ageing. The results indicate divergent longitudinal trajectories of the inflammatory markers, but a consistent positive association between both CRP and IL-6 with the Hannum measure of age acceleration (EEAA). In Chapter 6, a phenome-wide association study of a novel epigenetic clock incorporating inflammatory and immune markers ± DNA methylation PhenoAge ± is conducted, primarily in relation to cognitive outcomes, but also to a range of other health phenotypes. Here, the epigenetic biomarker displayed cross-sectional associations with various cognitive outcomes at the age of ~70 years in LBC1936. However, adjusting for early life cognitive ability attenuated the associations, indicative of a reverse causation whereby those with higher childhood intelligence were more likely to have higher intelligence and lower epigenetic age acceleration in later life. Chapters 7 and 8 focus on DNA methylation predictors of CRP and IL-6 and establishing their associations with cognitive ability. The results from Chapter 7 suggest that a DNA methylation proxy for CRP may provide a more stable index of chronic inflammation compared to serum levels of the inflammatory protein. Additionally, the effect sizes of the association between the methylation proxy and cognitive ability were slightly larger than that of the serum measure, indicating it may better capture the relationship between inflammation and cognitive performance. Chapter 8 revealed similar results, with a DNA methylation proxy for IL-6 showing associations with previously established correlates of IL-6, and with general cognitive ability in the Generation Scotland cohort. These results highlight the utility of DNA methylation proxies of inflammatory mediators to gain additional insight into the relationship between inflammation and cognitive function. The final empirical chapter - Chapter 9 - coalesces the work of the thesis by assessing the aforementioned epigenetic clock and inflammation-related DNA methylation signatures that were previously investigated in blood, in post-mortem brain tissue in 14 of the LBC1936 participants. This chapter additionally examines how the DNA methylation patterns relate to burdens of the primary tissue-resident immune cell of the central nervous system - microglia. The results of this chapter provide preliminary evidence that the hippocampus may be particularly susceptible to epigenetic ageing and indicate a tentative link between a higher DNA methylation PhenoAge in the brain and increased microglial burdens. However, given the small sample size of this work, these initial patterns need further confirmation. Overall, the work presented in this thesis establishes evidence for a relationship between inflammation, DNA methylation and cognitive ability. Increased inflammation and lower cognitive ability was found to associate with accelerated biological ageing. Furthermore, novel inflammation-associated methylation patterns were developed and related to cognitive performance in order to improve our understanding of the interplay between inflammation and age-related health outcomes."]},{"key":"dc:title","label":"Title","values":["Relationship between inflammation, DNA methylation and cognitive ability"]},{"key":"dc:title.alternative","label":"Alternative Title","values":["Investigating the relationship between inflammation, DNA methylation and cognitive ability"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Marioni, Riccardo","Spires-Jones, Tara","Mcintosh, Andrew","McColl, Barry"],"dc:contributor.sponsor":["Wellcome Trust"],"dc:creator":["Stevenson, Anna Jane"],"dc:date.accessioned":["2021-10-18T10:47:50Z"],"dc:date.available":["2021-10-18T10:47:50Z"],"dc:date.issued":["2021-07-31"],"dc:description.abstract":["Maintenance of cognitive function in older age is becoming increasingly relevant due to the ageing population and the personal and socioeconomic consequences associated with cognitive decline and dementia. Identification of the determinants of cognitive impairment in older age is thus critical. The role of inflammation has become a key focus in the field of cognitive ageing. Whereas inflammatory dysregulation may be evident in age-related cognitive decline, the extent, directionality, and progression of the association is still not clear. Additional approaches are needed to delineate the relationship. Alongside inflammation, there is increasing interest in the role of the epigenetic mechanism of DNA methylation in cognitive ageing. The aim of this thesis is to investigate the associations between inflammatory markers (C-reactive protein [CRP] and interleukin-6 [IL-6]), DNA methylation, and cognitive ability. A variety of approaches are utilised to examine these interrelationships in two large cohort datasets ± the Lothian Birth Cohort 1936 (LBC1936; n=1,091) and Generation Scotland (GS; n=7,028). Following introductory chapters presenting overviews of cognitive ability, inflammation and DNA methylation, and summarising the two population cohorts, the empirical work of the thesis is presented in Chapters 5 to 9. Chapters 5 and 6 focus on investigating the association between DNA methylation-based biomarkers of ageing ('epigenetic clocks') ZiWh boWh inflammaWion and cognitive ability, respectively. In Chapter 5, the dynamics of CRP and IL-6 are investigated over the eighth decade, and two epigenetic clocks ± labelled Hannum and Horvath - are used to investigate the relationship between the two inflammatory markers and accelerated epigenetic ageing. The results indicate divergent longitudinal trajectories of the inflammatory markers, but a consistent positive association between both CRP and IL-6 with the Hannum measure of age acceleration (EEAA). In Chapter 6, a phenome-wide association study of a novel epigenetic clock incorporating inflammatory and immune markers ± DNA methylation PhenoAge ± is conducted, primarily in relation to cognitive outcomes, but also to a range of other health phenotypes. Here, the epigenetic biomarker displayed cross-sectional associations with various cognitive outcomes at the age of ~70 years in LBC1936. However, adjusting for early life cognitive ability attenuated the associations, indicative of a reverse causation whereby those with higher childhood intelligence were more likely to have higher intelligence and lower epigenetic age acceleration in later life. Chapters 7 and 8 focus on DNA methylation predictors of CRP and IL-6 and establishing their associations with cognitive ability. The results from Chapter 7 suggest that a DNA methylation proxy for CRP may provide a more stable index of chronic inflammation compared to serum levels of the inflammatory protein. Additionally, the effect sizes of the association between the methylation proxy and cognitive ability were slightly larger than that of the serum measure, indicating it may better capture the relationship between inflammation and cognitive performance. Chapter 8 revealed similar results, with a DNA methylation proxy for IL-6 showing associations with previously established correlates of IL-6, and with general cognitive ability in the Generation Scotland cohort. These results highlight the utility of DNA methylation proxies of inflammatory mediators to gain additional insight into the relationship between inflammation and cognitive function. The final empirical chapter - Chapter 9 - coalesces the work of the thesis by assessing the aforementioned epigenetic clock and inflammation-related DNA methylation signatures that were previously investigated in blood, in post-mortem brain tissue in 14 of the LBC1936 participants. This chapter additionally examines how the DNA methylation patterns relate to burdens of the primary tissue-resident immune cell of the central nervous system - microglia. The results of this chapter provide preliminary evidence that the hippocampus may be particularly susceptible to epigenetic ageing and indicate a tentative link between a higher DNA methylation PhenoAge in the brain and increased microglial burdens. However, given the small sample size of this work, these initial patterns need further confirmation. Overall, the work presented in this thesis establishes evidence for a relationship between inflammation, DNA methylation and cognitive ability. Increased inflammation and lower cognitive ability was found to associate with accelerated biological ageing. Furthermore, novel inflammation-associated methylation patterns were developed and related to cognitive performance in order to improve our understanding of the interplay between inflammation and age-related health outcomes."],"dc:identifier.uri":["https://hdl.handle.net/1842/38167","http://dx.doi.org/10.7488/era/1434"],"dc:language.iso":["en"],"dc:publisher":["The University of Edinburgh"],"dc:relation.hasversion":["McCartney DL, Stevenson AJ, Hillary RF, Walker RM, Bermingham ML, Morris SW, et al. Epigenetic signatures of starting and stopping smoking. EBioMedicine. 2018;37:214-20","Stevenson AJ, McCartney DL, Harris SE, Taylor AM, Redmond P, Starr JM, et al. Trajectories of inflammatory biomarkers over the eighth decade and their associations with immune cell profiles and epigenetic ageing. Clinical epigenetics. 2018;10(1):159-.","Stevenson AJ, McCartney DL, Hillary RF, Redmond P, Taylor AM, Zhang Q, et al. Childhood intelligence attenuates the association between biological ageing and health outcomes in later life. Translational Psychiatry. 2019;9(1):323","Stevenson AJ, McCartney DL, Hillary RF, Campbell A, Morris SW, Bermingham ML, et al. Characterisation of an inflammation-related epigenetic score and its association with cognitive ability. Clinical epigenetics. 2020;12(1):113","McCartney DL, Hillary RF, Stevenson AJ, Ritchie SJ, Walker RM, Zhang Q, et al. Epigenetic prediction of complex traits and death. Genome Biology. 2018;19(1):136","McCartney DL, Stevenson AJ, Walker RM, Gibson J, Morris SW, Campbell A, et al. Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease. Alzheimers Dement (Amst). 2018;10:429- 37.","Stevenson AJ, McCartney DL, Hillary RF, Campbell A, Morris SW, Bermingham ML, et al. Characterisation of an inflammation-related epigenetic score and its association with cognitive ability. bioRxiv. 2019:802009","Hillary RF, Stevenson AJ, Cox SR, McCartney DL, Harris SE, Seeboth A, et al. An epigenetic predictor of death captures multi-modal measures of brain health. Molecular Psychiatry. 2019.","Stevenson AJ, Gadd DA, Hillary RF, McCartney DL, Campbell A, Walker RM, et al. Creating and validating a DNA methylation-based proxy for Interleukin-6. medRxiv. 2020:2020.07.20.20156935.","Conole ELS, Stevenson AJ, Green C, Harris SE, Maniega SM, Harris MA, et al. An epigenetic proxy of chronic inflammation outperforms serum levels as a biomarker of brain ageing. medRxiv. 2020:2020.10.08.20205245"],"dc:subject":["Alzheimer's Disease","epigenetic changes","DNA methylation","epigenetic clocks","predicted age","inflammation and cognitive ability","DNA methylation PhenoAge","microglia"],"dc:title":["Relationship between inflammation, DNA methylation and cognitive ability"],"dc:title.alternative":["Investigating the relationship between inflammation, DNA methylation and cognitive ability"],"dc:type":["Thesis or Dissertation"],"dc:type.qualificationlevel":["Doctoral"],"dc:type.qualificationname":["PhD Doctor of Philosophy"],"others:access_status":["open.access"]},"updated_at":"2026-11-19T03:35:01Z"}